MedPath

Treatment satisfaction in patients with systemic lupus erythematosus

Not Applicable
Conditions
Systemic lupus erythematosus
Registration Number
JPRN-UMIN000036207
Lead Sponsor
Rheumatic Disease Center, Kurashiki Medical Center
Brief Summary

Patient satisfaction was categorized into two types: 32 of satisfied and 8 of unsatisfied. Maximum dose of CS was significantly higher in unsatisfied patients. HRQOL was significantly higher in satisfied patients. Logistic analysis revealed satisfied patients was related to high score of HRQOL, never usage of steroid pulse, improvement in ability to remember things since taking current medication, and high score of current SLEDAI.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patients without therapeutic agents

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of treatment satisfaction between conventional immunosuppressive agents and newly approved drugs
Secondary Outcome Measures
NameTimeMethod
Factors affecting treatment satisfaction
© Copyright 2025. All Rights Reserved by MedPath